The ANswer within the microEnvironment: Malignant pleural mesothelioma resistance to Old and NEw drugs

Early detection of esophageal squamous cell carcinoma with the Cytosponge coupled with molecular biomarkers and machine learning

Approaching recurrence and resistance mechanisms in esophagogastric adenocarcinomas from the prospective MEMORI trial

A randomized, 2x2 biomarker prevention trial of low-dose aspirin and metformin in colon cancer patients

Exploiting the peptidome of atypical teratoid/rhabdoid tumors - characterization of novel tumor-associated antigens for immunotherapy in order to maintain long-term remissions

Patient-derived models for intratumor functional heterogeneity and its implications for personalized medicine

Bispecific antibodies in Lymphoma: Microenvironmental profiling to predict treatment response and uncover immunogenic resistance mechanisms

Precision medicine in cholangiocarcinoma: accurate tools for early detection and identification of PRMT5 as a novel pharmacological target

Biomarkers for diagnosis and prognosis of endometrial carcinoma

Biomarkers of tumor recurrence in pancreatic cancer

K-RAS mutations and DNA repair function in NSCLC

Harnessing BRCAness as a therapeutic target in high-risk pediatric solid tumors

MicroRNAs methylation and expression profiling for identification of breast cancer patients at high risk to develop distant metastases

Hijacking stroma antigens for CAR-T cell immunotherapy of PDAC

Breast    Clinical impact of intratumor heterogeneity in metastatic breast cancer

Cancer evolution and identification of relapse-initiating cells

Characterization of stromal and innate lymphoid cell populations involved in immunotherapy resistance in High-Grade Serous Ovarian

Validation of multiparametric models and Circulating and imaging biomarkers to improve Lung cancer EARLY detection

Circulating Tumor Cells as Biomarker for Minimal Residual Disease in Prostate Cancer

A randomized phase II study for tertiary prevention of squamocellular cancer of head and neck (SCCHN) with a dietary intervention

Impact of dietary intervention on tumor immunity

Defeating Recurrence and resistance in AML:Multigenomic Approaches to analyse heterogeneity

Dual epigenetic targeting and immunotherapy to fight against cancer

An integrated approach for epigenetic risk assessment and biomarker development for breast cancer in prospective cohorts / Identifying early epigenetic predictors of breast cancer risk and their etiology determinants

Implementation of (epi)genetic and metabolic networks in the targeting of T-cell prolymphocytic leukemia

Detection of early esophageal cancer by near-infrared fluorescence molecular endoscopy

Early prediction of efficacy of endocrine therapy in breast cancer: pilot study and validation with 18F Fluoroestradiol (FES) PET/CT

An integrated European platform to conduct translational studies in myelodysplastic syndromes based on the EuroBloodNet infrastructure

Translational Research in Peripheral T-Cell Lymphomas: from characterization to novel targets

Cancer prevention through improved familial risk assessment and gene discovery

Fighting Resistance in CLL